Aldeyra Therapeutics, Inc.

Aldeyra Therapeutics is a biotechnology company researching and developing investigational medicines for immune-mediated diseases, including conditions affecting the eye. Its work includes reactive aldehyde species modulators and other therapeutic approaches intended to influence inflammatory biology. The company focuses on discovering and advancing drug candidates rather than offering contract development services. Individual regulatory submissions, clinical trial results and potential marketing authorizations should be evaluated from dated official disclosures because those statuses can change. Aldeyra provides current business information and investor communications through its corporate and investor relations websites.